CONBA(SH:600572) Qi Lu Wan Bao·2025-09-15 03:29Core Points - Shanghai Sunshine Pharmaceutical Procurement Network announced the suspension of procurement qualifications for acetylcysteine effervescent tablets produced by Zhejiang Jinhua Kang En Bei Biological Pharmaceutical Co., Ltd. [1] - The suspension is based on the National Medical Products Administration's announcement regarding 28 batches of non-compliant drugs [1]. Company Overview - Zhejiang Jinhua Kang En Bei Biological Pharmaceutical Co., Ltd. is a subsidiary of Zhejiang Kang En Bei Pharmaceutical Co., Ltd. (600572) and specializes in chemical pharmaceuticals [1]. - The company holds a leading position in specialized chemical raw materials and freeze-dried, controlled-release formulations in China [1]. - It is recognized as a key pharmaceutical enterprise in Zhejiang Province and a national high-tech enterprise [1]. - The company was established in April 1958 and became a member of Kang En Bei Group in September 1996, achieving indirect listing in 2007 [1]. - In April 2020, the Zhejiang Provincial State-owned Assets Supervision and Administration Commission became the actual controlling shareholder [1].